Inogen, Inc.
NMS: INGNLive Quote
📈 ZcoreAI Score
Our AI model analyzes Inogen, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get INGN Z-Score →About Inogen, Inc.
Healthcare
Medical Devices
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
📊 Fundamental Analysis
Inogen, Inc. demonstrates a profit margin of -6.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported 2.0% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is -12.4%, which indicates that capital utilization is currently under pressure.
At a current price of $6.33, INGN currently sits at the 26th percentile of its 52-week range (Range: $5.34 - $9.13).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$172.38M
Trailing P/E
--
Forward P/E
-20.42
Beta (5Y)
1.71
52W High
$9.13
52W Low
$5.34
Avg Volume
279K
Day High
Day Low